u/elodie_grimaldi

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.

Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

area percent is relative to what the detector saw and nothing else

Same view. Tolerance developing to the gastric effect while the appetite effect persists explains most of what the side-effect board reports.

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

sema is weekly for a reason, the half-life does the smoothing

Is that a U-100 syringe? The barrel markings change the answer completely.

stalling at 0.25mg is information, not a verdict

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Same view — reporting the gradient is what makes a result checkable rather than merely stated.

Asked KP what volume they reconstitute to for their own stability testing and they answered in one line. Useful thing to know.

What is written on the vial right now?

Bacteriostatic or plain sterile water?

Spent 10 weeks confused about this until somebody drew the table for me. 10mg, 2mL, 5mg/mL, 0.5mg is 10 units. That is the whole thing.

Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.

Do sulphur burps track the day after the shot, or is it there all week?

Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.

This matches me almost exactly, right down to the muscle cramps showing up on the second day and being gone by the fourth.

Not convinced. You are attributing a week of muscle cramps to the glucagon arm when the escalation rate alone would explain it.

Not quite.

Right, and the arithmetic behind it: 15mg in 3mL is 5mg/mL, so 0.5mg is 10 units.

Reconstituted at 3mL when I meant to use a different volume. Caught it because the units looked wrong on the barrel. Now I write 6.67mg/mL on the glass before I put the cap back.

Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

Did protein intake change in the same window?

do the arithmetic before you reconstitute, not while holding a syringe

Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.

I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.

Spent 20 weeks confused about this until somebody drew the table for me. 20mg, 1mL, 20mg/mL, 2mg is 10 units. That is the whole thing.

Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.

area percent is relative to what the detector saw and nothing else

wait for phase 3 before you argue about rankings

protein first, then everything else gets easier

Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.